Sign inJoin waitlistJoin the waitlist

CH

Cheryl Ho

Hematology & Oncology

Credentials: ·

Research

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)
Journal of Clinical Oncology · 2017 · 335 citations
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Nature Medicine · 2023 · 149 citations
Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer
Review · Clinical Lung Cancer · 2006 · 114 citations

AD
Angela Davies
10 papers
David Gandara
8 papers · 1 as a fellow
AB
Alan Bates
7 papers
Primo Lara
6 papers
SS
Sophie Sun
6 papers
DL
Derick Lau
5 papers
DA
Deepu Alex
4 papers
Julia Naso
4 papers · 4 as a resident
KS
Kasmintan Schrader
4 papers
NC
Negar Chooback
3 papers
AS
Adrian Sacher
2 papers
MT
Michael Tanaka
2 papers